首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1676126

全球哺乳動物細胞發酵技術市場研究報告-產業分析、規模、佔有率、成長、趨勢與預測 2025 年至 2033 年

Global Mammalian Cell Fermentation Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球哺乳動物細胞發酵技術市場規模預計將從 2024 年的 524.2 億美元成長到 2033 年的 1165.3 億美元，在 2026 年至 2033 年的預測期內呈現 9.28% 的強勁年複合成長率(CAGR)。

隨著對生物製藥和生物製劑的需求不斷成長，哺乳動物細胞發酵技術市場將大幅成長。哺乳動物細胞發酵是治療性蛋白質、單株抗體和疫苗生產的關鍵過程，對於生物製藥產業至關重要。慢性病的日益普及和對個人化醫療的日益關注正在推動對哺乳動物細胞發酵技術的投資，進一步推動市場擴張。

技術進步在塑造哺乳動物細胞發酵技術市場的未來方面發揮著至關重要的作用。生物反應器設計、細胞培養基和製程最佳化的創新正在提高哺乳動物細胞發酵過程的效率和可擴展性。此外，自動化和資料分析的整合正在改善發酵過程的監控和控制，從而提高產量並縮短生產時間。隨著製造商不斷創新和開發新的解決方案，哺乳動物細胞發酵技術市場可能會在各種生物製藥應用中得到更廣泛的應用。

此外，對法規遵循和品質保證的日益重視正在影響哺乳動物細胞發酵技術市場的成長軌跡。隨著監管機構對生物製藥生產實施更嚴格的指導方針，對符合這些標準的發酵技術的需求預計將上升。這一趨勢正在推動技術提供者和生物製藥公司之間的合作，以開發確保合規性並提高產品品質的綜合解決方案。隨著市場的不斷發展，技術、法規遵循和品質管理的整合將成為成功的關鍵驅動力。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：哺乳動物細胞發酵技術公司的競爭格局

哺乳動物細胞發酵技術市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

Lonza

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

Sartorius AG

公司概況
公司收入
產品
最新動態

AstraZeneca

公司概況
公司收入
產品
最新動態

Bristol-Myers Squibb

公司概況
公司收入
產品
最新動態

Amgen

公司概況
公司收入
產品
最新動態

Gilead Sciences

公司概況
公司收入
產品
最新動態

Moderna Inc.

公司概況
公司收入
產品
最新動態

Regeneron Pharmaceuticals

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR112112214

Global Mammalian Cell Fermentation Technology Market size is anticipated to grow from USD 52.42 Billion in 2024 to USD 116.53 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.28% during the forecast period of 2026 to 2033.

The Mammalian Cell Fermentation Technology Market is poised for significant growth as the demand for biopharmaceuticals and biologics continues to rise. Mammalian cell fermentation is a critical process in the production of therapeutic proteins, monoclonal antibodies, and vaccines, making it essential for the biopharmaceutical industry. The increasing prevalence of chronic diseases and the growing focus on personalized medicine are driving investments in mammalian cell fermentation technologies, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the mammalian cell fermentation technology market. Innovations in bioreactor design, cell culture media, and process optimization are enhancing the efficiency and scalability of mammalian cell fermentation processes. Additionally, the integration of automation and data analytics is improving the monitoring and control of fermentation processes, enabling higher yields and reduced production times. As manufacturers continue to innovate and develop new solutions, the mammalian cell fermentation technology market is likely to see increased adoption across various biopharmaceutical applications.

Moreover, the growing emphasis on regulatory compliance and quality assurance is influencing the mammalian cell fermentation technology market's growth trajectory. As regulatory agencies implement stricter guidelines for biopharmaceutical production, the demand for fermentation technologies that meet these standards is expected to rise. This trend is driving collaboration between technology providers and biopharmaceutical companies to develop integrated solutions that ensure compliance and enhance product quality. As the market continues to evolve, the integration of technology, regulatory compliance, and quality management will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

Chinese Hamster Ovary (CHO) Cell Fermentation
Human Embryonic Kidney (HEK) Cell Fermentation
Baby Hamster Kidney (BHK) Cell Fermentation
Murine Myeloma Cell Fermentation
Others

By Application

Monoclonal Antibodies
Recombinant Proteins
Vaccines
Hormones
Enzymes
Others

By End-Use

Biopharmaceutical Companies
CMOs & CDMOs
Academic & Research Institutes
COMPANIES PROFILED
Thermo Fisher Scientific Inc.
Merck KGaA
Danaher
Lonza
F. Hoffmann-La Roche Ltd
Sartorius AG
AstraZeneca
Bristol-Myers Squibb
Amgen
Gilead Sciences
Moderna Inc.
Regeneron Pharmaceuticals.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Chinese Hamster Ovary (CHO) Cell Fermentation Historic and Forecast Sales By Regions
5.4. Human Embryonic Kidney (HEK) Cell Fermentation Historic and Forecast Sales By Regions
5.5. Baby Hamster Kidney (BHK) Cell Fermentation Historic and Forecast Sales By Regions
5.6. Murine Myeloma Cell Fermentation Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
6.4. Recombinant Proteins Historic and Forecast Sales By Regions
6.5. Vaccines Historic and Forecast Sales By Regions
6.6. Hormones Historic and Forecast Sales By Regions
6.7. Enzymes Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data Analysis By End-Use
7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
7.4. CMOs & CDMOs Historic and Forecast Sales By Regions
7.5. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MAMMALIAN CELL FERMENTATION TECHNOLOGY COMPANIES

9.1. Mammalian Cell Fermentation Technology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Merck KGaA
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Danaher
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Lonza
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. F. Hoffmann-La Roche Ltd
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Sartorius AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. AstraZeneca
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Bristol-Myers Squibb
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Amgen
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Gilead Sciences
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Moderna Inc.
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Regeneron Pharmaceuticals
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Type (USD MN)
Chinese Hamster Ovary (CHO) Cell Fermentation Market Sales By Geography (USD MN)
Human Embryonic Kidney (HEK) Cell Fermentation Market Sales By Geography (USD MN)
Baby Hamster Kidney (BHK) Cell Fermentation Market Sales By Geography (USD MN)
Murine Myeloma Cell Fermentation Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Vaccines Market Sales By Geography (USD MN)
Hormones Market Sales By Geography (USD MN)
Enzymes Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
CMOs & CDMOs Market Sales By Geography (USD MN)
Academic & Research Institutes Market Sales By Geography (USD MN)
Global Mammalian Cell Fermentation Technology Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Mammalian Cell Fermentation Technology Report
Market Research Process
Market Research Methodology
Global Mammalian Cell Fermentation Technology Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Type
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Type (USD MN)
Chinese Hamster Ovary (CHO) Cell Fermentation Market Sales By Geography (USD MN)
Human Embryonic Kidney (HEK) Cell Fermentation Market Sales By Geography (USD MN)
Baby Hamster Kidney (BHK) Cell Fermentation Market Sales By Geography (USD MN)
Murine Myeloma Cell Fermentation Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Vaccines Market Sales By Geography (USD MN)
Hormones Market Sales By Geography (USD MN)
Enzymes Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
CMOs & CDMOs Market Sales By Geography (USD MN)
Academic & Research Institutes Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.